Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

RENALYTIX PLC

Published over 1 year ago

June 29, 2023 6:01 PM EDTFDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseView this release →

Renalytix
1460 Broadway , New York, NY 10036, USA

Wait! Don't miss the next news release from RENALYTIX PLC

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Create your free Filing Feed to easily stay up to date with the companies you care about.

Setup Free Alerts →